Stock Comparison

ARGX vs ARWR

argenx NV ADR and Arrowhead Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

ARWR

Arrowhead Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$55.44B

$11.11B

P/E (TTM)

39.4

—

Forward P/E

34.0

111.1

Price/Sales

11.7

17.9

Price/Book

7.5

18.2

EV/EBITDA

33.9

27.9

Dividend Yield

—

Profitability

Net Margin

31.40%

-48.40%

Operating Margin

30.00%

-191.60%

Return on Equity

20.20%

-42.40%

Return on Assets

8.86%

-7.22%

Growth (YoY)

Revenue Growth

62.60%

-86.40%

Earnings Growth

114.00%

9.80%

Price & Risk

Beta

-0.0

1.3

52-Week High

$934.62

$84.55

52-Week Low

$510.06

$14.30

Analyst Target

$1,041.14

$89.08

Compare ARGX and ARWR your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.